Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.8M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
+283K
-
Total reported value, excl. options
-
$177M
-
Value change
-
+$1.82M
-
Put/Call ratio
-
0.18
-
Number of buys
-
27
-
Number of sells
-
-19
-
Price
-
$6.71
Significant Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q1 2024
71 filings reported holding FHTX - Foghorn Therapeutics Inc. - COMMON STOCK as of Q1 2024.
Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
of 55.8M outstanding shares and own 47.43% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (2.69M shares), RAYMOND JAMES & ASSOCIATES (2.23M shares), Euclidean Capital LLC (1.57M shares), BlackRock Inc. (1.32M shares), VANGUARD GROUP INC (1.1M shares), Artal Group S.A. (721K shares), Alphabet Inc. (501K shares), GEODE CAPITAL MANAGEMENT, LLC (448K shares), and STATE STREET CORP (438K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.